Skip to main content
SpringerLink
Log in

Bedeutung immunologischer Prozesse im 2./3. Trimenon

  • Chapter
  • First Online:
Fehlgeburten Totgeburten Frühgeburten

  • 4405 Accesses

Zusammenfassung

Störungen immunologischer Prozesse während der Schwangerschaft können Präeklampsien, HELLP-Syndrome, intrauterine Wachstumsretardierungen sowie Fehl- und Frühgeburten verursachen. Es werden verschiedene Proteine und Hormone beschrieben, deren Dysregulation eine Schwangerschaft gefährden können. Zudem werden Marker genannt, die auf einen pathologischen Schwangerschaftsverlauf hinweisen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Abrahams VM et al. (2004) Macrophages and apoptotic cell clearance during pregnancy. Am J Reprod Immunol 51(4): 275–282

    Article  PubMed  Google Scholar 

  • Alijotas-Reig J, Llurba E, Gris JM (2014) Potentiating maternal immune tolerance in pregnancy: a new challenging role for regulatory T cells. Placenta 35(4): 241–248

    Article  CAS  PubMed  Google Scholar 

  • Almkvist J, Karlsson A (2004) Galectins as inflammatory mediators. Glycoconj J 19(7-9): 575–581

    Article  PubMed  Google Scholar 

  • Areia A et al. (2015) Can membrane progesterone receptor alpha on T regulatory cells explain the ensuing human labour? J Reprod Immunol 113: 22–26

    Article  PubMed  Google Scholar 

  • Auvynet C et al. (2013) Galectin-1 promotes human neutrophil migration. Glycobiology 23(1): 32–42

    Article  CAS  PubMed  Google Scholar 

  • Bamberger AM et al. (1997) Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab 82(9): 3173–3175

    Article  CAS  PubMed  Google Scholar 

  • Baumann R (2010) Physiologie. Thieme, Stuttgart

    Google Scholar 

  • Bianchi DW et al. (1996) Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 93(2): 705–708

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Blidner AG, Rabinovich GA (2013) ‚Sweetening‘ pregnancy: galectins at the fetomaternal interface. Am J Reprod Immunol 69(4): 369–382

    Article  CAS  PubMed  Google Scholar 

  • Bozic M et al. (2004) Galectin-1 and galectin-3 in the trophoblast of the gestational trophoblastic disease. Placenta 25(10): 797–802

    Article  CAS  PubMed  Google Scholar 

  • Brune T et al. (2004) The increased lysis of fetal cells in the mother after pregnancies complicated by pre-eclampsia or HELLP syndrome is not the result of a specific anti-fetal cytotoxicity of the mother. Am J Reprod Immunol 51(2): 174–179

    Article  PubMed  Google Scholar 

  • Canellada A et al. (2002) Interleukin regulation of asymmetric antibody synthesized by isolated placental B cells. Am J Reprod Immunol 48(4): 275–282

    Article  CAS  PubMed  Google Scholar 

  • Canellada A et al. (2002) In vitro modulation of protective antibody responses by estrogen, progesterone and interleukin-6. Am J Reprod Immunol 48(5): 334–343

    Article  PubMed  Google Scholar 

  • Cannon JG (2000) Inflammatory cytokines in nonpathological states. News Physiol Sci 15: 298–303

    CAS  PubMed  Google Scholar 

  • Challis JR, Smith SK (2001) Fetal endocrine signals and preterm labor. Biol Neonate 79(3-4): 163–167

    Article  CAS  PubMed  Google Scholar 

  • Chernyshov VP et al. (2008) Th1 and Th2 in human IVF pregnancy with allogenic fetus. Am J Reprod Immunol 59(4): 352–358

    Article  CAS  PubMed  Google Scholar 

  • Damsker JM, Hansen AM, Caspi RR (2010) Th1 and Th17 cells: adversaries and collaborators. Ann N Y Acad Sci 1183: 211–221

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dautzenberg FM, Hauger RL (2002) The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 23(2): 71–77

    Article  CAS  PubMed  Google Scholar 

  • Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129(6): 1339–1350

    Article  CAS  PubMed  Google Scholar 

  • Garin MI et al. (2007) Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. Blood 109(5): 2058–2065

    Article  CAS  PubMed  Google Scholar 

  • Gil CD, Gullo CE, Oliani SM (2010) Effect of exogenous galectin-1 on leukocyte migration: modulation of cytokine levels and adhesion molecules. Int J Clin Exp Pathol 4(1): 74–84

    PubMed  PubMed Central  Google Scholar 

  • Hauger RL et al. (2006) Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol Disord Drug Targets 5(4): 453–479

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hillhouse EW, Grammatopoulos DK (2002) Role of stress peptides during human pregnancy and labour. Reproduction 124(3): 323–329

    Article  CAS  PubMed  Google Scholar 

  • Hillier SL et al. (1991) Microbiologic causes and neonatal outcomes associated with chorioamnion infection. Am J Obstet Gynecol 165(4 Pt 1): 955–961

    Article  CAS  PubMed  Google Scholar 

  • Hobel CJ et al. (1999) Maternal plasma corticotropin-releasing hormone associated with stress at 20 weeks' gestation in pregnancies ending in preterm delivery. Am J Obstet Gynecol 180(1 Pt 3): S257–263

    Article  Google Scholar 

  • van der Hoorn ML (2010) Clinical and immunologic aspects of egg donation pregnancies: a systematic review. Hum Reprod Update 16(6): 704–712

    Article  PubMed  Google Scholar 

  • van der Hoorn ML et al. (2014) Differential immunoregulation in successful oocyte donation pregnancies compared with naturally conceived pregnancies. J Reprod Immunol 101-102: 96–103

    Article  PubMed  Google Scholar 

  • Iwakura Y, Ishigame H (2006) The IL-23/IL-17 axis in inflammation. J Clin Invest 116(5): 1218–1222

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jacobsson B, Mattsby-Baltzer I, Hagberg H (2005) Interleukin-6 and interleukin-8 in cervical and amniotic fluid: relationship to microbial invasion of the chorioamniotic membranes BJOG 112(6): 719–724

    Article  CAS  PubMed  Google Scholar 

  • Jeschke U et al. (2005) Expression of glycodelin A in decidual tissue of preeclamptic, HELLP and intrauterine growth-restricted pregnancies. Virchows Arch 446(4): 360–368

    Article  CAS  PubMed  Google Scholar 

  • Jeschke U et al. (2007) Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas. Placenta 28(11–12): 1165–1173

    Article  CAS  PubMed  Google Scholar 

  • Jeschke U et al. (2013) Expression and function of galectins in the endometrium and at the human feto-maternal interface. Placenta 34(10): 863–872

    Article  CAS  PubMed  Google Scholar 

  • Jiang TT et al. (2014) Regulatory T cells: new keys for further unlocking the enigma of fetal tolerance and pregnancy complications. J Immunol 192(11): 4949–4956

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kalantaridou SN et al. (2003) Roles of reproductive corticotropin-releasing hormone. Ann N Y Acad Sci 997: 129–135

    Article  CAS  PubMed  Google Scholar 

  • Karteris E et al. (2003) Reduced expression of corticotropin-releasing hormone receptor type-1 alpha in human preeclamptic and growth-restricted placentas. J Clin Endocrinol Metab 88(1): 363–370

    Article  CAS  PubMed  Google Scholar 

  • Karteris E et al. (2005) Preeclampsia is associated with impaired regulation of the placental nitric oxide-cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides. J Clin Endocrinol Metab 90(6): 3680–3687

    Article  CAS  PubMed  Google Scholar 

  • Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21(4): 467–476

    Article  CAS  PubMed  Google Scholar 

  • Koopman LA et al. (2003) Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 198(8): 1201–1212

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kopcow HD et al. (2008) T cell apoptosis at the maternal-fetal interface in early human pregnancy, involvement of galectin-1. Proc Natl Acad Sci U S A 105(47): 18472–18477

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kovacs-Solyom F et al. (2010) Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1. Immunol Lett 127(2): 108–118

    Article  CAS  PubMed  Google Scholar 

  • Kubach J et al. (2007) Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function. Blood 110(5): 1550–1558

    Article  CAS  PubMed  Google Scholar 

  • Lange F et al. (2009) Galectin-1 induced activation of the mitochondrial apoptotic pathway: evidence for a connection between death-receptor and mitochondrial pathways in human Jurkat T lymphocytes. Histochem Cell Biol 132(2): 211–223

    Article  CAS  PubMed  Google Scholar 

  • Makrigiannakis A et al. (2001) Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nat Immunol 2(11): 1018–1024

    Article  CAS  PubMed  Google Scholar 

  • Makrigiannakis A et al. (2007) Maternal serum corticotropin-releasing hormone and ACTH levels as predictive markers of premature labor. Int J Gynaecol Obstet 97(2): 115–159

    Article  CAS  PubMed  Google Scholar 

  • Maquoi E et al. (1997) Changes in the distribution pattern of galectin-1 and galectin-3 in human placenta correlates with the differentiation pathways of trophoblasts. Placenta 18(5-6): 433–439

    Article  CAS  PubMed  Google Scholar 

  • Martinez-Varea A et al. (2014) Relationship between maternal immunological response during pregnancy and onset of preeclampsia. J Immunol Res 2014: 210–241

    Article  Google Scholar 

  • Maynard SE et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111(5): 649–658

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Minas V et al. (2007) Abortion is associated with increased expression of FasL in decidual leukocytes and apoptosis of extravillous trophoblasts: a role for CRH and urocortin. Mol Hum Reprod 13(9): 663–673

    Article  CAS  PubMed  Google Scholar 

  • Molvarec A et al. (2015) Increased circulating interleukin-17 levels in preeclampsia. J Reprod Immunol 112: 53–57

    Article  CAS  PubMed  Google Scholar 

  • Perone MJ et al. (2009) Suppression of autoimmune diabetes by soluble galectin-1. J Immunol 182(5): 2641–2653

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Petsas G et al. (2012) Aberrant expression of corticotropin-releasing hormone in pre-eclampsia induces expression of FasL in maternal macrophages and extravillous trophoblast apoptosis. Mol Hum Reprod 18(11): 535–545

    Article  CAS  PubMed  Google Scholar 

  • Polgar B et al. (2004) Urinary progesterone-induced blocking factor concentration is related to pregnancy outcome. Biol Reprod 71(5): 1699–1705

    Article  CAS  PubMed  Google Scholar 

  • Rees LH et al. (1975) Possible placental origin of ACTH in normal human pregnancy. Nature 254(5501): 620–622

    Article  CAS  PubMed  Google Scholar 

  • Reiner SL (2007) Development in motion: helper T cells at work. Cell 129(1): 33–36

    Article  CAS  PubMed  Google Scholar 

  • Reister F et al. (1999) The distribution of macrophages in spiral arteries of the placental bed in pre-eclampsia differs from that in healthy patients. Placenta 20(2–3): 229–233

    Article  CAS  PubMed  Google Scholar 

  • Reister F et al. (2001) Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 81(8): 1143–1152

    Article  CAS  PubMed  Google Scholar 

  • Romero R et al. (1993) Amniotic fluid interleukin-6 determinations are of diagnostic and prognostic value in preterm labor. Am J Reprod Immunol 30(2–3): 167–183

    Article  CAS  PubMed  Google Scholar 

  • Romero R et al. (2012) Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol 206(2): 124 e1–19

    Article  PubMed  Google Scholar 

  • Saito S et al. (2007) Inadequate tolerance induction may induce pre-eclampsia. J Reprod Immunol 76(1–2): 30–39

    Article  CAS  PubMed  Google Scholar 

  • Sasaki A et al. (1988) Isolation and characterization of a corticotropin-releasing hormone-like peptide from human placenta. J Clin Endocrinol Metab 67(4): 768–773

    Article  CAS  PubMed  Google Scholar 

  • Schlembach D, Lang U (2008) Preeclampsia and pregnancy-induced hypertension - diseases determined in the uterus? Gynakol Geburtshilfliche Rundsch 48(4): 225–230

    Article  PubMed  Google Scholar 

  • Schlembach SV, Klein E, Lapaire O, Ramoni A, Stepan H (2015) Der sFlt-1/PlGF-Quotient in Prädiktion und Diagnostik der Präeklampsie. Frauenarzt 56(10): 858–865

    Google Scholar 

  • Sharma S (2014) Natural killer cells and regulatory T cells in early pregnancy loss. Int J Dev Biol 58(2–4): 219–229

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shevach EM (2001) Certified professionals: CD4(+)CD25(+) suppressor T cells. J Exp Med 193(11): F41–46

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Somerset DA et al. (2004) Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology 112(1): 38–43

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Steinman L (2007) A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13(2): 139–145

    Article  CAS  PubMed  Google Scholar 

  • Szekeres-Bartho J, Wegmann TG (1996) A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J Reprod Immunol 31(1–2): 81–95

    Article  CAS  PubMed  Google Scholar 

  • Szekeres-Bartho J et al. (1985) The mechanism of the inhibitory effect of progesterone on lymphocyte cytotoxicity: II. Relationship between cytotoxicity and the cyclooxygenase pathway of arachidonic acid metabolism. Am J Reprod Immunol Microbiol 9(1): 19–22

    Article  CAS  PubMed  Google Scholar 

  • Szekeres-Bartho J et al. (1989) Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction. Cell Immunol 122(2): 281–294

    Article  CAS  PubMed  Google Scholar 

  • Szekeres-Bartho J et al. (1996) The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am J Reprod Immunol 35(4): 348–351

    Article  CAS  PubMed  Google Scholar 

  • Tan C et al. (2010) Antigen-specific Th9 cells exhibit uniqueness in their kinetics of cytokine production and short retention at the inflammatory site. J Immunol 185(11): 6795–6801

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Than NG et al. (2008) Chorioamnionitis and increased galectin-1 expression in PPROM - an anti-inflammatory response in the fetal membranes? Am J Reprod Immunol 60(4): 298–311

    Article  PubMed  PubMed Central  Google Scholar 

  • Velez DR et al. (2008) Patterns of cytokine profiles differ with pregnancy outcome and ethnicity. Hum Reprod 23(8): 1902–1909

    Article  CAS  PubMed  Google Scholar 

  • Verlohren S et al. (2012) The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol 206(1): 58 e1–8

    Article  PubMed  Google Scholar 

  • Weissenbacher T et al. (2013) Diagnostic biomarkers of pro-inflammatory immune-mediated preterm birth. Arch Gynecol Obstet 287(4): 673–685

    Article  CAS  PubMed  Google Scholar 

  • Williams Z et al. (2009) Foreign fetal cells persist in the maternal circulation. Fertil Steril 91(6): 2593–2595

    Article  PubMed  Google Scholar 

  • Winkler M, Rath W (1996) The role of cytokines in the induction of labor, cervical ripening and rupture of the fetal membranes. Z Geburtshilfe Neonatol 200(suppl 1): 1–12

    PubMed  Google Scholar 

  • Wong MT et al. (2010) Regulation of human Th9 differentiation by type I interferons and IL-21. Immunol Cell Biol 88(6): 624–631

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Universität München, Maistrasse 11, 80337, München, Germany

    Aurelia Vattai

  2. Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Maistrasse 11, 80337, München, Germany

    Udo Jeschke

Authors
  1. Aurelia Vattai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Udo Jeschke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Gynäkologische Endokrinologie und Reproduktionsmedizin, Medizinische Universität Innsbruck, Innsbruck, Austria

    Bettina Toth

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Vattai, A., Jeschke, U. (2017). Bedeutung immunologischer Prozesse im 2./3. Trimenon. In: Toth, B. (eds) Fehlgeburten Totgeburten Frühgeburten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-50424-6_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-50424-6_6

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-50423-9

  • Online ISBN: 978-3-662-50424-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation